Seroquel Tablet, Extended Release
Product Images NDC 0310-0281

9 FDA label images from Astrazeneca Pharmaceuticals Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Seroquel (NDC 0310-0281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure diagram showing the molecular formula of the active ingredients in SEROQUEL XR, a formulation by AstraZeneca Pharmaceuticals LP. The structure includes two components represented within brackets, consistent with quetiapine fumarate salt chemistry.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Image 02)

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Image 02)
A Kaplan-Meier curve chart comparing the proportion of patients with relapse (%) over time in months between two groups labeled PLA and QTP XR. The y-axis shows relapse proportion from 0 to 100%, and the x-axis shows time from 0 to 7 months. The PLA group shows a steadily increasing relapse proportion, while the QTP XR group shows a lower relapse rate over the same period.*
FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Image 03)

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Image 03)
A Kaplan-Meier curve showing the proportion of patients with relapse over time (weeks) comparing two groups: QTP+ LI/VAL (dashed line) and PLA+ LI/VAL (solid line). The y-axis represents the proportion of patients with relapse (%) from 0 to 100%, and the x-axis represents time in weeks from 0 to 100. The graph illustrates a lower relapse proportion over time for the QTP+ LI/VAL group compared to the PLA+ LI/VAL group.*
FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Image 04)

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Image 04)
A line graph depicting the proportion of patients with relapse (%) over time (weeks). The graph compares two groups labeled as QTP+ LI/VAL and PLA+ LI/VAL, showing their respective relapse rates over a 100-week period.*
FDA Label Image

Seroquel Xr 50 mg 60 Tablets Bottle Label (Image 05)

Seroquel Xr 50 mg 60 Tablets Bottle Label (Image 05)
Packaging label for SEROQUEL XR 50 mg extended-release tablets. The label shows a quantity of 60 tablets and includes the active ingredient quetiapine fumarate. It is marked for prescription use only and includes a medication guide requirement. The labeler is AstraZeneca Pharmaceuticals LP.*
FDA Label Image

Seroquel Xr 150 mg 60 Tablets Bottle Label (Image 06)

Seroquel Xr 150 mg 60 Tablets Bottle Label (Image 06)
The packaging label for SEROQUEL XR 150 mg extended-release tablets by AstraZeneca Pharmaceuticals LP displays the NDC 0310-0281-60 and indicates a bottle containing 60 tablets. It specifies the active ingredient quetiapine and includes directions to dispense a medication guide to patients. The label also notes the product is for once-daily prescription use.*
FDA Label Image

Seroquel Xr 200 mg 60 Tablets Bottle Label (Image 07)

Seroquel Xr 200 mg 60 Tablets Bottle Label (Image 07)
Label of SEROQUEL XR 200 mg extended-release tablets by AstraZeneca Pharmaceuticals LP. The label indicates a package of 60 tablets and includes the active ingredient quetiapine fumarate. The design features a red, white, black, and purple color scheme with dosing and dispensing instructions.*
FDA Label Image

Seroquel Xr 300 mg 60 Tablets Bottle Label (Image 08)

Seroquel Xr 300 mg 60 Tablets Bottle Label (Image 08)
Label for SEROQUEL XR 300 mg extended-release tablets by AstraZeneca Pharmaceuticals LP, displaying the strength of 300 mg, quantity of 60 tablets, and the active ingredient quetiapine. The label also includes a note stating it is Rx only and that a medication guide must be dispensed to patients.*
FDA Label Image

Seroquel Xr 400 mg 60 Tablets Bottle Label (Image 09)

Seroquel Xr 400 mg 60 Tablets Bottle Label (Image 09)
Label of SEROQUEL XR 400 mg extended-release tablets by AstraZeneca Pharmaceuticals LP. The label displays the product name, strength of 400 mg, package count of 60 tablets, and instructions that it is Rx only with a medication guide requirement. The label also notes the active ingredient as quetiapine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.